Different Treatments in Chronic Pain Patients.

NCT ID: NCT05768477

Last Updated: 2024-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-06

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to compare different treatment options in a chronic pain population. The main questions it aims to answer are:

* What is the effectiveness of the different therapy options in the pain center of Sint-Lucas on outcomes related to pain and disability?
* What are predictive factors for the different therapy options in the pain center of Sint-Lucas? Which factors predict improvement in pain related outcomes?

Participant data will be gathered as part of their routine care. They can be advised to 4 different treatment options:

* Consultations with the pain specialist
* Interventions by the pain specialist (infiltrations, denervations)
* Baxter therapy
* Interdisciplinary treatment

Researchers will compare patients with different dominant pain mechanisms to see which treatment are most effective for which dominant pain mechanisms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the present study is to describe the natural flow of the chronic pain patients at the pain center AZ Sint-Lucas. Patients will be examined before starting the therapy, and receive standardized questionnaires at several fixed time points (before, during, and after their therapy trajectory). Information about the present dominant pain mechanism will be gathered during the examination. The questionnaires will gather demographic data, information about the present dominant pain mechanism, psychosocial factors, catastrophizing, fear and avoidance, illness perceptions, fatigue and information about therapy success. During the examination, typical signs of a dominant nociplastic pain mechanism will be gathered. By processing the data of the questionnaires and the examination, knowledge about (1) the amount of patients with a dominant nociplastic pain mechanism at intake, (2) the treatment trajectory for a specific diagnosis, and (3) the prediction of the therapy effect and prognosis will be obtained.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain Nociplastic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chronic pain patients

Chronic pain patients with a dominant nociceptive pain mechanism, a dominant neuropathic pain mechanism and a dominant nociplastic pain mechanism. They will receive different treatments: Consultations, Interventions (injections, denervations...), Baxter therapy and interdisciplinary treatment.

Consultation

Intervention Type OTHER

Consultation with the pain specialist, which might entail prescription of medication of vitamins.

Interventions

Intervention Type PROCEDURE

Facet injections, nerve denervations, infiltrations, Qutenza, Spinal Cord Stimulation, Transcutaneous Electrical Nerve Stimulation

Baxter therapy

Intervention Type DRUG

Ketamine or Linisol baxter therapy

Interdisciplinary therapy

Intervention Type BEHAVIORAL

Interdisciplinary therapy provided by the physiotherapist, psychologist and occupational therapist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Consultation

Consultation with the pain specialist, which might entail prescription of medication of vitamins.

Intervention Type OTHER

Interventions

Facet injections, nerve denervations, infiltrations, Qutenza, Spinal Cord Stimulation, Transcutaneous Electrical Nerve Stimulation

Intervention Type PROCEDURE

Baxter therapy

Ketamine or Linisol baxter therapy

Intervention Type DRUG

Interdisciplinary therapy

Interdisciplinary therapy provided by the physiotherapist, psychologist and occupational therapist.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults
* Chronic pain patients
* Dutch speaking, or good understanding

Exclusion Criteria

* Adults unable to give consent
* Adults who do not understand Dutch
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Ghent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jessica Van Oosterwijck

Role: PRINCIPAL_INVESTIGATOR

Department of Rehabilitation Sciences, Faculty of Health Sciences, Ghent University, Belgium

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AZ St Lucas

Ghent, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jessica Van Oosterwijck, Professor

Role: CONTACT

+32 9 332 69 19

Elise Cnockaert

Role: CONTACT

+32 9 332 56 35

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elise Cnockaert

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-39

Identifier Type: REGISTRY

Identifier Source: secondary_id

ONZ-2022-0090

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.